MTVA
Price
$0.70
Change
+$0.01 (+1.45%)
Updated
Jun 18 closing price
Capitalization
13.71M
PMVP
Price
$1.10
Change
+$0.01 (+0.92%)
Updated
Jun 18 closing price
Capitalization
57.15M
49 days until earnings call
Interact to see
Advertisement

MTVA vs PMVP

Header iconMTVA vs PMVP Comparison
Open Charts MTVA vs PMVPBanner chart's image
MetaVia
Price$0.70
Change+$0.01 (+1.45%)
Volume$34.8K
Capitalization13.71M
PMV Pharmaceuticals
Price$1.10
Change+$0.01 (+0.92%)
Volume$92.56K
Capitalization57.15M
MTVA vs PMVP Comparison Chart in %
Loading...
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTVA vs. PMVP commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTVA is a Hold and PMVP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (MTVA: $0.70 vs. PMVP: $1.10)
Brand notoriety: MTVA and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MTVA: 4% vs. PMVP: 38%
Market capitalization -- MTVA: $13.71M vs. PMVP: $57.15M
MTVA [@Biotechnology] is valued at $13.71M. PMVP’s [@Biotechnology] market capitalization is $57.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTVA’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • MTVA’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, both MTVA and PMVP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTVA’s TA Score shows that 2 TA indicator(s) are bullish while PMVP’s TA Score has 6 bullish TA indicator(s).

  • MTVA’s TA Score: 2 bullish, 3 bearish.
  • PMVP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, PMVP is a better buy in the short-term than MTVA.

Price Growth

MTVA (@Biotechnology) experienced а -6.98% price change this week, while PMVP (@Biotechnology) price change was -2.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

MTVA is expected to report earnings on Mar 20, 2025.

PMVP is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMVP($57.1M) has a higher market cap than MTVA($13.7M). PMVP YTD gains are higher at: -27.152 vs. MTVA (-65.517). MTVA has higher annual earnings (EBITDA): -25.79M vs. PMVP (-87.97M). PMVP has more cash in the bank: 160M vs. MTVA (11.2M). MTVA has less debt than PMVP: MTVA (118K) vs PMVP (1.11M). MTVA (0) and PMVP (0) have equivalent revenues.
MTVAPMVPMTVA / PMVP
Capitalization13.7M57.1M24%
EBITDA-25.79M-87.97M29%
Gain YTD-65.517-27.152241%
P/E RatioN/AN/A-
Revenue00-
Total Cash11.2M160M7%
Total Debt118K1.11M11%
FUNDAMENTALS RATINGS
MTVA: Fundamental Ratings
MTVA
OUTLOOK RATING
1..100
1
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MTVAPMVP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 10 days ago
78%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MTVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHH23.952.04
+9.31%
Park Ha Biological Technology Co Ltd
SDHC18.160.56
+3.18%
Smith Douglas Homes Corp
HSBC59.190.67
+1.14%
HSBC Holdings PLC
NSPR2.420.01
+0.41%
InspireMD
AM18.130.04
+0.22%
Antero Midstream Corp

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with HOOK. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+1.16%
HOOK - MTVA
44%
Loosely correlated
-0.38%
PMVP - MTVA
35%
Loosely correlated
+0.92%
MCRB - MTVA
32%
Poorly correlated
+5.60%
KPRX - MTVA
30%
Poorly correlated
+2.72%
NERV - MTVA
29%
Poorly correlated
-1.63%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with XNCR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+0.92%
XNCR - PMVP
41%
Loosely correlated
+0.60%
CLLS - PMVP
39%
Loosely correlated
+2.19%
VERV - PMVP
38%
Loosely correlated
-2.28%
COGT - PMVP
38%
Loosely correlated
-4.99%
TERN - PMVP
37%
Loosely correlated
+2.56%
More